These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22410249)

  • 1. Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect.
    Nie YY; Da YJ; Zheng H; Yang XX; Jia L; Wen CH; Liang LS; Tian J; Chen ZL
    Bioorg Med Chem; 2012 Apr; 20(8):2747-61. PubMed ID: 22410249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.
    Kim TW; Yoo BW; Lee JK; Kim JH; Lee KT; Chi YH; Lee JY
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1649-54. PubMed ID: 22264484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
    Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
    J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and evaluation of novel potent angiotensin II receptor 1 antagonists.
    Bao X; Zhu W; Yuan W; Zhu X; Yan Y; Tang H; Chen Z
    Eur J Med Chem; 2016 Nov; 123():115-127. PubMed ID: 27474928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.
    Casimiro-Garcia A; Filzen GF; Flynn D; Bigge CF; Chen J; Davis JA; Dudley DA; Edmunds JJ; Esmaeil N; Geyer A; Heemstra RJ; Jalaie M; Ohren JF; Ostroski R; Ellis T; Schaum RP; Stoner C
    J Med Chem; 2011 Jun; 54(12):4219-33. PubMed ID: 21557540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of new fluorine substituted derivatives as angiotensin II receptor antagonists with anti-hypertension and anti-tumor effects.
    Da YJ; Yuan WD; Xin T; Nie YY; Ye Y; Yan YJ; Liang LS; Chen ZL
    Bioorg Med Chem; 2012 Dec; 20(24):7101-11. PubMed ID: 23122933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NO-sartans: a new class of pharmacodynamic hybrids as cardiovascular drugs.
    Breschi MC; Calderone V; Digiacomo M; Martelli A; Martinotti E; Minutolo F; Rapposelli S; Balsamo A
    J Med Chem; 2004 Nov; 47(23):5597-600. PubMed ID: 15509155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
    Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
    Zhang J; Wang JL; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Bioorg Med Chem; 2012 Jul; 20(14):4208-16. PubMed ID: 22727371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of a new angiotensin II receptor antagonist.
    Zheng HL; Zhu WB; Wu D; Da YJ; Yan YJ; Bian J; Chen ZL
    Drug Res (Stuttg); 2014 Dec; 64(12):656-62. PubMed ID: 24573978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
    Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
    Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revelation on the potency of α(1) -blockers - parallel blockade of angiotensin II receptor: a new finding.
    Yadav MR; Gandhi HP; Naik PP; Giridhar R
    Pharm Biol; 2012 Apr; 50(4):439-42. PubMed ID: 22136253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme and angiotensin II receptor subtype 1 inhibitors restitute hypertensive internal anal sphincter in the spontaneously hypertensive rats.
    De Godoy MA; Rattan S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):725-34. PubMed ID: 16648368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympatho-inhibitory properties of various AT1 receptor antagonists.
    Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
    J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, binding studies and in vivo biological evaluation of novel non-peptide antihypertensive analogues.
    Mavromoustakos T; Moutevelis-Minakakis P; Kokotos CG; Kontogianni P; Politi A; Zoumpoulakis P; Findlay J; Cox A; Balmforth A; Zoga A; Iliodromitis E
    Bioorg Med Chem; 2006 Jul; 14(13):4353-60. PubMed ID: 16546395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and pharmacological evaluation of 5-oxo-1,2,4-oxadiazole derivatives as AT1 antagonists with antihypertension activities.
    Zhu W; Bao X; Ren H; Liao P; Zhu W; Yan Y; Wang L; Chen Z
    Clin Exp Hypertens; 2016; 38(5):435-42. PubMed ID: 27362285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.
    Da YJ; Yuan WD; Zhu LF; Chen ZL
    Arzneimittelforschung; 2012 Dec; 62(12):637-43. PubMed ID: 23203543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
    Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
    Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Phenyl indole derivatives as AT1 antagonists with anti-hypertension activities: Design, synthesis and biological evaluation.
    Zhu W; Bao X; Ren H; Da Y; Wu D; Li F; Yan Y; Wang L; Chen Z
    Eur J Med Chem; 2016 Jun; 115():161-78. PubMed ID: 27017546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive activity of Salvia elegans Vahl. (Lamiaceae): ACE inhibition and angiotensin II antagonism.
    Jiménez-Ferrer E; Badillo FH; González-Cortazar M; Tortoriello J; Herrera-Ruiz M
    J Ethnopharmacol; 2010 Jul; 130(2):340-6. PubMed ID: 20488233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.